Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 12 articles: HTML format

Single Articles

June 2026
1. WANG Y, Xie Y, Zhao Q
   Novel therapeutic strategies for metastatic castration?resistant prostate cancer: Beyond androgen receptor pathway inhibition (Review).
   Int J Oncol. 2026;68:69.
   PubMed     Abstract available
   
   
   February 2026
2. HUANG Y, Mao J, Li X
   Emerging biomarkers in prostate cancer diagnosis and treatment: Insights into genetic, RNA and metabolic markers (Review).
   Int J Oncol. 2026;68:15.
   PubMed     Abstract available
   
   
   September 2025
3. LONG Z, Chang Y, Zhu K, Chen Z, et al
   Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis?related genes (Review).
   Int J Oncol. 2025;67:77.
   PubMed     Abstract available
   
   
   March 2025
4. MASUD N, Aldahish A, Iczkowski KA, Kale A, et al
   [Retracted] Zinc finger protein?like 1 is a novel neuroendocrine biomarker for prostate cancer.
   Int J Oncol. 2025;66:16.
   PubMed     Abstract available
   
   
   February 2025
5. GRAVINA GL, Marampon F, Giusti I, Carosa E, et al
   [Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
   Int J Oncol. 2025;66:11.
   PubMed     Abstract available
   
   
   November 2024
6. IIDA K, Zheng R, Shen R, Nanus DM, et al
   [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
   Int J Oncol. 2024;65:106.
   PubMed     Abstract available
   
   
   
7. XU Y, Zhang G, Liu Y, Liu Y, et al
   Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review).
   Int J Oncol. 2024;65:104.
   PubMed     Abstract available
   
   
   September 2024
8. ZHENG XM, Zhang P, Liu MH, Chen P, et al
   [Retracted] MicroRNA?30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
   Int J Oncol. 2024;65:82.
   PubMed     Abstract available
   
   
   February 2024
9. NAEEM AA, Abdulsamad SA, Zeng H, He G, et al
   FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
   Int J Oncol. 2024;64:18.
   PubMed     Abstract available
   
   
   
10. ZHONG K, Luo W, Li N, Tan X, et al
    CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
    Int J Oncol. 2024;64:20.
    PubMed     Abstract available
    
    
    January 2024
11. SUN X, Xin S, Zhang Y, Jin L, et al
    [Corrigendum] Long non?coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Int J Oncol. 2024;64:5.
    PubMed     Abstract available
    
    
    November 2023
12. FENG K, Liu C, Wang W, Kong P, et al
    Emerging proteins involved in castration?resistant prostate cancer via the AR?dependent and AR?independent pathways (Review).
    Int J Oncol. 2023;63:127.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum